Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
bmed0063@OX.AC.UK

Research groups

Lak Group

Rathi Puliyadi

Lab Manager

As a Lab Manager, I oversee laboratory safety and provide administrative and hands-on support to the team.

Recent publications

Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models.

Rodriguez-Berriguete G. et al, (2023), Clin Cancer Res, 29, 1631 - 1642

Development of DNA polymerase theta inhibitors as tumour specific radiosensitisers

Prevo R. et al, (2022), RADIOTHERAPY AND ONCOLOGY, 170, S371 - S372

basis for combining atovaquone-mediated hypoxia alleviation with immunotherapy plus radiotherapy

Rodriguez-Berriguete G. et al, (2022), RADIOTHERAPY AND ONCOLOGY, 170, S113 - S114

Targeting TOPK sensitises tumour cells to radiation-induced damage by enhancing replication stress.

Herbert KJ. et al, (2021), Cell Death Differ, 28, 1333 - 1346

External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus Increase.

Pokrovska TD. et al, (2020), Cancers (Basel), 12

More publications